Nanocarry is developing a new class of therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. Using a proprietary “Plug and Play” approach, Nanocarry’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.

Biotechnology

Nanotechnology

Therapeutics

Nanocarry

Revital Mandil Levin

Ayelet Zafran

Michal Roytman

Rachela Popovtzer

Oshra Betzer

Ashley Shapiro

Adam Antebi

The leadership team at Nanocarry has a history of experience in research and development, customer service, business development, and teaching. They have also been involved in various aspects of the nanotechnology field including particles, brain research, engineering, and cancer treatment.

Leadership Team

CEO and Executive Team

Founding Team

Leadership Team

About

Team members

Other teams at Nanocarry

CEO and Executive Team

Founding Team